The New Jersey Supreme Court unanimously upheld a lower court’s 2014 ruling that consumers with state law claims blaming the manufacturers of generic versions of the heartburn drug Reglan for not adequately warning about neurological side effects, are not preempted by federal law. The lawsuits claim that generics manufacturers, including Pliva Inc., Actavis Elizabeth LLC, and Teva Pharmaceuticals USA Inc., delayed changing the labels of generic Reglan, known chemically as metoclopramide so that it conformed with the brand-name version of the drug. The New Jersey Supreme Court said that by not changing the labels to match that of the brand-name drug, the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.